Vnitřní lékařství 6/2020

PŮVODNÍ PRÁCE Deriváty sulfonylurey a riziko hypoglykemie u diabetiků 2. typu E42 | VNITŘNÍ LÉKAŘSTVÍ / Vnitř Lék 2020; 66(6): e35–e42 /  www.casopisvnitrnilekarstvi.cz 25. Salvo F, Moore N, Arnaud M, Robinson P, Raschi E, De Ponti F, Bégaud B, Pariente A. Addition of dipeptidyl peptidase-4 inhibitors to sulphonylureas and risk of hypoglycae- mia: systematic review and meta-analysis. BMJ. 2016; 353: i2231. doi: 10.1136/bmj.i2231. 26. Whitmer RA, Karter AJ, Yaffe K, Quesenberry CP Jr, Selby JV. Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus. JAMA. 2009; 301(15): 1565–1572. doi: 10.1001/jama.2009.460. 27. Bramlage P, Gitt AK, Binz C, Krekler M, Deeg E, Tschöpe D. Oral antidiabetic treatment in type-2 diabetes in the elderly: balancing the need for glucose control and the risk of hypoglycemia. Cardiovasc Diabetol. 2012; 11: 122. doi: 10.1186/1475-2840-11-122. 28. Bremer JP, Jauch-Chara K, Hallschmid M, Schmid S, Schultes B. Hypoglycemia una- wareness in older compared with middle-aged patients with type 2 diabetes. Diabetes Care. 2009; 32(8): 1513–1517. doi: 10.2337/dc09-0114. 29. Vimalananda VG, DeSotto K, Chen T, Mullakary J, Schlosser J, Archambeault C, Peck J, Cassidy H, Conlin PR, Evans S, McConnell M, Shirley E. A Quality Improvement Program to Reduce Potential Overtreatment of Diabetes Among Veterans at High Risk of Hypoglyce- mia. Diabetes Spectr. 2017; 30(3): 211–216. doi: 10.2337/ds16-0006. 30. Liatis S, Mylona M, Kalopita S, Papazafiropoulou A, Karamagkiolis S, Melidonis A, Xilomenos A, Ioannidis I, Kaltsas G, Lanaras L, Papas S, Basagiannis C, Kokkinos A. Hypo- glycaemia requiring medical assistance in patients with diabetes: a prospective multi- centre survey in tertiary hospitals. Diabetes Metab. 2015; 41(2): 126–131. doi: 10.1016/j. diabet.2014.10.006. 31. Breuer HW, Ptak P. (Hypoglycemia – frequency, causes, induced costs). Dtsch Med Wo- chenschr. 2012; 137(19): 988–992. doi: 10.1055/s-0031-1299014. 32. Nelson JM, Dufraux K, Cook PF. The relationship between glycemic control and falls in older adults. J AmGeriatr Soc. 2007; 55(12): 2041–2044. doi: 10.1111/j.1532-5415.2007.01430.x. 33. Fulcher G, Singer J, Castañeda R, Fraige Filho F, Maffei L, Snyman J, Brod M. The psychoso- cial and financial impact of non-severe hypoglycemic events on people with diabetes: two international surveys. J Med Econ. 2014; 17(10): 751–761. doi: 10.3111/13696998.2014.946992. 34. Parekh TM, Raji M, Lin YL, Tan A, Kuo YF, Goodwin JS. Hypoglycemia after antimicrobial drug prescription for older patients using sulfonylureas. JAMA Intern Med. 2014; 174(10): 1605–1612. doi: 10.1001/jamainternmed.2014.3293. 35. Clayton D, Woo V, Yale JF. Hypoglycemia. Can J Diabetes. 2013; 37 Suppl 1: S69–71. doi: 10.1016/j.jcjd.2013.01.022. 36. Stahn A, Pistrosch F, Ganz X, Teige M, Koehler C, Bornstein S, Hanefeld M. Relationship between hypoglycemic episodes and ventricular arrhythmias in patients with type 2 dia- betes and cardiovascular diseases: silent hypoglycemias and silent arrhythmias. Diabetes Care. 2014; 37(2): 516–520. doi: 10.2337/dc13-0600. 37. Bron M, Marynchenko M, Yang H, Yu AP, Wu EQ. Hypoglycemia, treatment discontinua- tion, and costs in patients with type 2 diabetes mellitus on oral antidiabetic drugs. Post- grad Med. 2012; 124(1): 124–132. doi: 10.3810/pgm.2012.01.2525. 38. Majumdar SR, Hemmelgarn BR, Lin M, McBrien K, Manns BJ, Tonelli M. Hypoglycemia associated with hospitalization and adverse events in older people: population-based co- hort study. Diabetes Care. 2013; 36(11): 3585–3590. doi: 10.2337/dc13-0523. 39. Nordin C. The case for hypoglycaemia as a proarrhythmic event: basic and clinical evi- dence. Diabetologia. 2010; 53(8): 1552–1561. doi: 10.1007/s00125-010-1752-6. 40. Holstein A, Hammer C, Hahn M, Kulamadayil NS, Kovacs P. Severe sulfonylure- a-induced hypoglycemia: a problem of uncritical prescription and deficiencies of diabetes care in geriatric patients. Expert Opin Drug Saf. 2010; 9(5): 675–681. doi: 10.1517/14740338.2010.492777. 41. Gerstein HC, Miller ME, Byington RP, Goff DC Jr, Bigger JT, Buse JB, Cushman WC, Genuth S, Ismail-Beigi F, Grimm RH Jr, Probstfield JL, Simons-Morton DG, Friedewald WT. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008; 358(24): 2545–2559. doi: 10.1056/NEJMoa0802743. 42. Patel A, MacMahon S, Chalmers J, Neal B, Billot L, Woodward M, Marre M, Cooper M, Glasziou P, Grobbee D, Hamet P, Harrap S, Heller S, Liu L, Mancia G, Mogensen CE, Pan C, Poulter N, Rodgers A, Williams B, Bompoint S, de Galan BE, Joshi R, Travert F. Intensive blo- od glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008; 358(24): 2560–2572. doi: 10.1056/NEJMoa0802987. 43. Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, Reaven PD, Zieve FJ, Marks J, Davis SN, Hayward R, Warren SR, Goldman S, McCarren M, Vitek ME, Henderson WG, Huang GD. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med. 2009; 360(2): 129–139. doi: 10.1056/NEJMoa0808431. 44. Elliott WJ, Meyer PM. Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis. Lancet. 2007; 369(9557): 201–207. doi: 10.1016/S0140- 6736(07)60108-1. 45. Moen MF, Zhan M, Hsu VD, Walker LD, Einhorn LM, Seliger SL, Fink JC. Frequency of hypoglycemia and its significance in chronic kidney disease. Clin J Am Soc Nephrol. 2009; 4(6): 1121–1127. doi: 10.2215/CJN.00800209. 46. Ústav zdravotnických informací a statistiky ČR. (2019). Zdravotnická ročenka České re- publiky 2011. Retrieved November 5, 2019, from http://www.uzis.cz/katalog/rocenky/zdra- votnicka-rocenka-ceske-republiky-1961-az-2013. 47. Ústav zdravotnických informací a statistiky ČR. (2019). Zdravotnická ročenka České re- publiky 2015. Retrieved November 5, 2019, from http://www.uzis.cz/katalog/rocenky/ zdravotnicka-rocenka-ceske-republiky-1961-az-2013.